Dow Up 0.12% Nasdaq Up 1.35%

Novavax, Inc. (NVAX)

-NasdaqGS
5.01 Up 0.13(2.66%) Oct 20, 4:00PM EDT
|After Hours : 5.07 Up 0.06 (1.20%) Oct 20, 7:52PM EDT
Prev Close:4.88
Open:4.85
Bid:N/A
Ask:5.07 x 200
1y Target Est:10.07
Beta:1
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.82 - 5.04
52wk Range:2.68 - 6.95
Volume:2,733,296
Avg Vol (3m):3,220,050
Market Cap:1.19B
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVAX

Comparison

Symbol% ChgMkt Cap
NVAXUp 2.66%1.19B
MRKUp 0.06%155.91B
NVSUp 1.47%213.26B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):39.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.29
Quarterly EPS Est (Sep-14) :-0.07
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback